Design, synthesis and biological evaluation of novel DNA gyrase inhibitors and their siderophore mimic conjugates

Bioorg Chem. 2020 Jan:95:103550. doi: 10.1016/j.bioorg.2019.103550. Epub 2019 Dec 23.

Abstract

Bacterial DNA gyrase is an important target for the development of novel antibacterial drugs, which are urgently needed because of high level of antibiotic resistance worldwide. We designed and synthesized new 4,5,6,7-tetrahydrobenzo[d]thiazole-based DNA gyrase B inhibitors and their conjugates with siderophore mimics, which were introduced to increase the uptake of inhibitors into the bacterial cytoplasm. The most potent conjugate 34 had an IC50 of 58 nM against Escherichia coli DNA gyrase and displayed MIC of 14 µg/mL against E. coli ΔtolC strain. Only minor improvements in the antibacterial activities against wild-type E. coli in low-iron conditions were seen for DNA gyrase inhibitor - siderophore mimic conjugates.

Keywords: Antibiotics; Catechol; DNA gyrase; Inhibitors; Siderophore mimic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • Drug Design*
  • Microbial Sensitivity Tests
  • Molecular Mimicry*
  • Siderophores / pharmacology*
  • Thiazoles / chemistry*
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Siderophores
  • Thiazoles
  • Topoisomerase II Inhibitors